Xenitra Returns To Quarterly Gross Profit As Pharmaceuticals Launch
XEN: $0.002 +0.00% · MC: $14M
Xenitra reported positive quarterly gross profit, reversing a loss in the same quarter last year, as its newly operational pharmaceuticals division generated approximately $864,000 in sales. The company says its three-year procurement agreements provide for at least $12 million in purchases and target a further $5 million, while Web3 partnerships have supported more than $2 million in sales since April. Quarter-end bank cash rose 9% from June and more than doubled year on year to approximately $3 million.

Comments